Related Experiment Video
Updated: Jul 18, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Anemia and cost in Medicare patients with congestive heart failure
Craig A Solid1, Robert N Foley, David T Gilbertson
1Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minnesota, Minneapolis, MN 55404, USA.
Insights
Anemia in congestive heart failure (CHF) patients significantly increases Medicare costs. This study found anemia is linked to higher healthcare spending in elderly CHF patients.
Area of Science:
- Cardiology
- Geriatrics
- Health Economics
Background:
- Anemia is a common comorbidity in patients with congestive heart failure (CHF).
- The economic burden of anemia in CHF patients on healthcare systems is not well-defined.
Purpose of the Study:
- To determine the total cost to Medicare associated with anemia in congestive heart failure (CHF) patients.
- To quantify the increased medical expenditure linked to anemia in elderly CHF patients.
Main Methods:
- Utilized International Classification of Diseases, Ninth Revision, Clinical Modification codes to identify anemia, CHF, and comorbidities in 2002.
- Calculated total Medicare costs for 2003 based on identified patient cohorts.
- Performed statistical analysis to compare costs between CHF patients with and without anemia, adjusting for demographic and comorbidity factors.
Main Results:
- Anemia was present in 32% of CHF patients, associated with older age, female sex, non-white race, and greater comorbidity burden.
- CHF patients with anemia incurred higher per-member-per-month costs ($1781.01) compared to those without anemia ($1142.38), a ratio of 1.56.
- After adjusting for demographic and comorbidity factors, the cost ratio remained significant at 1.25, indicating anemia independently increases healthcare costs.
Conclusions:
- Anemia is a significant independent predictor of increased healthcare expenditure in elderly patients with congestive heart failure.
- Addressing anemia in CHF patients may lead to substantial cost savings for Medicare.
- This study highlights the economic impact of anemia as a comorbidity in chronic heart conditions.
Abstract:
The objective of this study was to examine the total cost to Medicare associated with the presence of anemia in congestive heart failure (CHF) patients. International Classification of Diseases, Ninth Revision, Clinical Modification codes were used to identify anemia, CHF, and comorbid conditions in 2002, and total Medicare costs were calculated for 2003. The mean patient age was 77.8 years. Anemia, present in 32% of CHF patients, was associated with older age, female sex, non-white race, and increasing burden of comorbidity. The total per-member-per-month cost in 2003 was $1781.01 among CHF patients with anemia in the preceding year compared with $1142.38 for CHF patients without anemia, a ratio of 1.56 (95% confidence interval, 1.5589-1.5592). When adjustment was made for baseline demographic factors and comorbid conditions, the corresponding ratio was 1.25 (95% confidence interval, 1.2546-1.2548). Anemia, a common association of CHF in elderly patients, is an antecedent association of increased societal medical expenditure.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
Heart Failure I: Introduction
Heart Failure III: Clinical Manifestations
